OHSU in the news

Based on OHSU research, FDA approves drug that reduces hearing loss in pediatric cancer patients

Oregon Public Broadcasting January 30, 2023
An OPB segment highlights the recent FDA approval of sodium thiosulfate, a drug studied for years by OHSU researchers that prevents treatment-induced hearing loss in pediatric cancer patients who receive the common chemotherapy drug Cisplatin. The segment includes insight from Kristin Knight, M.S., and Jennifer Boesche, whose child received cancer therapy at the hospital.

Could an annual booster be all you need to maintain COVID immunity?

Cosmos Magazine January 30, 2023
Research by Fikadu Tafesse, Ph.D., and Marcel Curlin, M.D., finds immunity against COVID-19 gathers strength with more time between vaccination and infection and suggests vaccine boosters should be spaced no more frequently than a year apart.

Are posture correctors useful?

Consumer Reports January 27, 2023
In a Consumer Reports story about various consumer products purporting to reduce back pain by improving posture, Scott Beadnell, DPT, says, “Generally, we think of those as gimmicks.”

OHSU study: Immune response to COVID-19 strengthens over time

KPTV January 27, 2023
Research by Fikadu Tafesse, Ph.D., and Marcel Curlin, M.D., finds immunity against COVID-19 gathers strength with more time between vaccination and infection and suggests vaccine boosters should be spaced no more frequently than a year apart.

Oregon colleges rethink approach to nursing educator gap

The Lund Report January 26, 2023
The Lund Report describes how the OHSU School of Nursing’s Oregon Nursing Education Academy, which aims to prepare 63 clinical nurse faculty and 92 nurse preceptors by 2026, is helping address a shortage of educators needed to teach the next generation of clinical nurses.
See more stories